Ушбу ишга иқтибос қилган ишлар

6 та иш

Иш: A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   МақолаTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.000002

2. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000207

3. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000020

4. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

   Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

   МақолаTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.262608

5. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360284

6. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   МақолаTuberculosis Research and EpidemiologyPLoS ONE20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360285